VINORELBINE - A HORSE OF A DIFFERENT COLOR

被引：17

作者：

PINEDO, HM

VANGROENINGEN, CJ

机构：

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1994年 / 12卷 / 09期

关键词：

D O I：

10.1200/JCO.1994.12.9.1745

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1745 / 1747

页数：3

共 21 条

[11] RANDOMIZED STUDY OF VINORELBINE AND CISPLATIN VERSUS VINDESINE AND CISPLATIN VERSUS VINORELBINE ALONE IN ADVANCED NON-SMALL-CELL LUNG-CANCER - RESULTS OF A EUROPEAN MULTICENTER TRIAL INCLUDING 612 PATIENTS [J].

LECHEVALIER, T ;

BRISGAND, D ;

DOUILLARD, JY ;

PUJOL, JL ;

ALBEROLA, V ;

MONNIER, A ;

RIVIERE, A ;

LIANES, P ;

CHOMY, P ;

CIGOLARI, S ;

GOTTFRIED, M ;

RUFFIE, P ;

PANIZO, A ;

GASPARD, MH ;

RAVAIOLI, A ;

BESENVAL, M ;

BESSEN, F ;

MARTINEZ, A ;

BERTHAUD, P ;

TURSZ, T .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (02) :360-367

[12] 5'-NOR ANHYDROVINBLASTINE - PROTOTYPE OF A NEW CLASS OF VINBLASTINE DERIVATIVES [J].

MANGENEY, P ;

ANDRIAMIALISOA, RZ ;

LALLEMAND, JY ;

LANGLOIS, N ;

LANGLOIS, Y ;

POTIER, P .

TETRAHEDRON, 1979, 35 (18) :2175-2179

[13] PHARMACOKINETICS OF VINORELBINE IN MAN [J].

MARQUET, P ;

LACHATRE, G ;

DEBORD, J ;

EICHLER, B ;

BONNAUD, F ;

NICOT, G .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 42 (05) :545-547

[14] PHASE I PHARMACOLOGIC STUDY OF A NEW VINCA ALKALOID - NAVELBINE [J].

MATHE, G ;

REIZENSTEIN, P .

CANCER LETTERS, 1985, 27 (03) :285-293

[15]

PEREZ JD, 1990, J CLIN ONCOL, V9, P2148

[16] ANTIPROLIFERATIVE ACTIVITY OF VINORELBINE (NAVELBINE) AGAINST 6 HUMAN-MELANOMA CELL-LINES [J].

PHOTIOU, A ;

SHEIKH, MN ;

BAFALOUKOS, D ;

RETSAS, S .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1992, 118 (04) :249-254

[17] PHARMACOKINETIC, BIOAVAILABILITY, AND FEASIBILITY STUDY OF ORAL VINORELBINE IN PATIENTS WITH SOLID TUMORS [J].

ROWINSKY, EK ;

NOE, DA ;

TRUMP, DL ;

WINER, EP ;

LUCAS, VS ;

WARGIN, WA ;

HOHNEKER, JA ;

LUBEJKO, B ;

SARTORIUS, SE ;

ETTINGER, DS ;

DONEHOWER, RC .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (09) :1754-1763

[18] PHASE-II TRIAL OF VINORELBINE DOXORUBICIN AS FIRST-LINE THERAPY OF ADVANCED BREAST-CANCER [J].

SPIELMANN, M ;

DORVAL, T ;

TURPIN, F ;

ANTOINE, E ;

JOUVE, M ;

MAYLEVIN, F ;

LACOMBE, D ;

ROUESSE, J ;

POUILLART, P ;

TURSZ, T ;

MERLE, S .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (09) :1764-1770

[19]

VERMORKEN JB, 1993, ANN ONCOL S4, V4, pS41

[20]

Zhou X J, 1992, Drugs, V44 Suppl 4, P1

← 1 2 3 →